HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is expected to report second quarter earnings results, after market close, on Tuesday 11th August 2020.
Analysts polled by Thomson Reuters anticipate second quarter loss of $ 0.08 per share.
Looking ahead, the full year loss are expected at $ 0.32 per share on the revenues of $ 11.29 million.
Previous Quarter Performance
HTG Molecular Diagnostics, Inc. reported loss for the first quarter of $ 0.08 per share, from the revenue of $ 2.23 million. According to street consensus, HTGM was expected to report 1Q20 loss of $ 0.10 per share from revenue of $ 3.04 million. The bottom line results beat street analysts by $ 0.02 or 20.00 percent, at the same time, top line results fell short of analysts by $ 0.81 million or 26.64 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of HTG Molecular Diagnostics, Inc.
Stock Performance
According to the previous trading day, closing price of HTGM was $ 0.64, representing a 137.04 % increase from the 52 week low of $ 0.27 and a 44.83 % decrease over the 52 week high of $ 1.16.
The company has a market capital of $ 42.94 million and is part of the Healthcare sector and Diagnostics & Research industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”HTGM” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
HTG Molecular Diagnostics, Inc. will be hosting a conference call at 4:30 PM eastern time on 11th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.htgmolecular.com
HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation (or platforms); consumables comprising assay kits; and software analytics that automate sample processing and profiles various molecular targets.
